Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer

被引:0
作者
Daisuke Takahari
Tetsuya Hamaguchi
Kenichi Yoshimura
Hitoshi Katai
Seiji Ito
Nozomu Fuse
Masaru Konishi
Hirofumi Yasui
Masanori Terashima
Masahiro Goto
Nobuhiko Tanigawa
Kuniaki Shirao
Takeshi Sano
Mitsuru Sasako
机构
[1] Aichi Cancer Center Hospital,Department of Clinical Oncology
[2] National Cancer Center Hospital,Gastrointestinal Oncology Division
[3] Kyoto University Hospital,Translational Research Center, Graduate School of Medicine
[4] National Cancer Center Hospital,Gastric Surgery Division
[5] Aichi Cancer Center Hospital,Department of Gastroenterological Surgery
[6] National Cancer Center Hospital East,Division of Gastrointestinal Oncology and Digestive Endoscopy
[7] National Cancer Center Hospital East,Division of Surgical Oncology
[8] Shizuoka Cancer Center,Division of Gastrointestinal Oncology
[9] Shizuoka Cancer Center,Division of Gastric Surgery
[10] Osaka Medical College,Cancer Chemotherapy Center
[11] Osaka Medical College,General and Gastroenterological Surgery
[12] Oita University,Department of Medical Oncology, Faculty of Medicine
[13] Cancer Institute Hospital,Department of Surgery
[14] Japanese Foundation for Cancer Research,Department of Surgery
[15] Hyogo College of Medicine,undefined
来源
Gastric Cancer | 2014年 / 17卷
关键词
Adjuvant chemotherapy; Gastric cancer; S-1; Cisplatin;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:383 / 386
页数:3
相关论文
共 30 条
[1]  
Sakuramoto S(2007)Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine N Engl J Med 357 1810-1820
[2]  
Sasako M(2011)Five-year outcomes of a randomized phase III trial comparing adjuvant chemotherapy with S-1 versus surgery alone in stage II or III gastric cancer J Clin Oncol 29 4387-4393
[3]  
Yamaguchi T(2008)S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial Lancet Oncol 9 215-221
[4]  
Kinoshita T(2011)Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer Cancer Chemother Pharmacol 67 1423-1428
[5]  
Fujii M(1998)Japanese Classification of Gastric Carcinoma—2nd English Edition Gastric Cancer 1 10-24
[6]  
Nashimoto A(2012)Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial Lancet 379 315-321
[7]  
Sasako M(undefined)undefined undefined undefined undefined-undefined
[8]  
Sakuramoto S(undefined)undefined undefined undefined undefined-undefined
[9]  
Katai H(undefined)undefined undefined undefined undefined-undefined
[10]  
Kinoshita T(undefined)undefined undefined undefined undefined-undefined